Meeder Advisory Services’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.01M Buy
35,296
+984
+3% +$87.7K 0.13% 114
2025
Q4
$2.71M Buy
34,312
+5,738
+20% +$450K 0.12% 120
2025
Q3
$2.28M Buy
28,574
+1,422
+5% +$121K 0.11% 138
2025
Q2
$2.47M Buy
27,152
+4,818
+22% +$440K 0.13% 128
2025
Q1
$2.09M Buy
22,334
+1,851
+9% +$166K 0.13% 133
2024
Q4
$1.86M Buy
20,483
+1,688
+9% +$161K 0.12% 133
2024
Q3
$1.95M Buy
18,795
+226
+1% +$23K 0.13% 130
2024
Q2
$1.8M Buy
18,569
+4,379
+31% +$404K 0.13% 131
2024
Q1
$1.28M Buy
14,190
+431
+3% +$36.5K 0.13% 136
2023
Q4
$1.1M Sell
13,759
-436
-3% -$32.8K 0.13% 139
2023
Q3
$1.01M Sell
14,195
-1,454
-9% -$109K 0.13% 135
2023
Q2
$1.21M Buy
15,649
+2,346
+18% +$182K 0.13% 135
2023
Q1
$1,000K Buy
13,303
+2,316
+21% +$172K 0.12% 152
2022
Q4
$866K Buy
+10,987
New +$824K 0.11% 179

Other funds holding CL

Meeder Advisory Services's CL Position: Q1 2026 in Review

Meeder Advisory Services increased its Colgate-Palmolive (CL) stake by 2.9% in Q1 2026, buying an estimated $87.7K and bringing the position to 35,296 shares worth $3.01M. The position accounts for 0.13% of the portfolio, ranked #114.

Meeder Advisory Services first reported a position in CL in Q4 2022 and has held it in 14 quarters since. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Meeder Advisory Services held 35,296 shares of Colgate-Palmolive worth $3.01M as of Q1 2026.
  • Meeder Advisory Services bought 984 Colgate-Palmolive shares in Q1 2026, an estimated $87.7K.
  • Colgate-Palmolive made up 0.13% of Meeder Advisory Services's portfolio in Q1 2026, its #114 holding.
  • Meeder Advisory Services first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 14 quarters since.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.